Research
Hormonal
Exercise improves postprandial satiety signaling (satiety quotient) but increases fasting hunger, leading to a net compensatory increase in energy intake that partially offsets energy expenditure.
Exercise increases both fasting hunger and post-meal satiety. The net effect is a partial compensation of about 30% of expended calories. Manage fasting hunger to maximize the net energy deficit.
GoodQualifiesHIGH confidence
First, there is an exercise-induced increase in fasting – or early morning – hunger. However, in contrast, exercise improves satiety by increasing the postprandial sensitivity to ingested nutrients consumed in meals... a small compensatory rise in EI has been observed in both men and women
Why this rating
Supported by multiple studies on appetite control and exercise.
Source
Appetite control and energy balance: impact of exercise
John E. Blundell et al. · Obesity Reviews · 2015
DOI 10.1111/obr.12257
narrative_reviewCited 338×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Long-term exercise produces a dose-dependent reduction in body weight and fat mass, refuting the media narrative that exercise nullifies energy expenditure through compensatory hunger.Strong
- Individual responses to exercise are highly variable (ranging from significant fat loss to weight gain) due to heterogeneous compensatory increases in energy intake and changes in body composition.Good
- Fat-free mass (FFM) and resting metabolic rate (RMR) are primary determinants of daily energy intake and meal size, challenging the adipocentric model that focuses solely on fat mass and leptin.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →